| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/02/2023 | 29.2% | Barclays | $12 → $10 | Maintains | Equal-Weight |
| 10/31/2023 | 29.2% | Stifel | $16 → $10 | Maintains | Hold |
| 10/18/2023 | 106.72% | Truist Securities | $23 → $16 | Maintains | Buy |
| 08/16/2023 | 287.6% | TD Cowen | $35 → $30 | Maintains | Outperform |
| 08/04/2023 | 158.4% | Barclays | $21 → $20 | Maintains | Equal-Weight |
| 06/27/2023 | 197.16% | Truist Securities | → $23 | Reiterates | Buy → Buy |
| 05/23/2023 | 132.56% | Jefferies | $22 → $18 | Maintains | Hold |
| 05/10/2023 | 197.16% | Truist Securities | $29 → $23 | Maintains | Buy |
| 05/10/2023 | 132.56% | Wells Fargo | $22 → $18 | Maintains | Equal-Weight |
| 02/14/2023 | 158.4% | Deutsche Bank | $23 → $20 | Maintains | Hold |
| 01/25/2023 | 184.24% | Wells Fargo | $23 → $22 | Maintains | Equal-Weight |
| 12/15/2022 | 197.16% | Barclays | $21 → $23 | Maintains | Equal-Weight |
| 11/04/2022 | 197.16% | Wells Fargo | $22 → $23 | Maintains | Equal-Weight |
| 11/02/2022 | 223% | Stifel | $28 → $25 | Downgrades | Buy → Hold |
| 10/25/2022 | 274.68% | Truist Securities | $30 → $29 | Maintains | Buy |
| 10/21/2022 | 184.24% | Wells Fargo | $26 → $22 | Maintains | Equal-Weight |
| 10/06/2022 | 197.16% | Deutsche Bank | → $23 | Initiates Coverage On | → Hold |
| 08/08/2022 | 481.4% | Cowen & Co. | $53 → $45 | Maintains | Outperform |
| 07/20/2022 | 300.52% | Truist Securities | $38 → $31 | Maintains | Buy |
| 07/01/2022 | 274.68% | Stifel | $49 → $29 | Maintains | Buy |
| 06/29/2022 | 171.32% | Barclays | → $21 | Initiates Coverage On | → Equal-Weight |
| 06/28/2022 | — | JMP Securities | Initiates Coverage On | → Market Perform | |
| 04/19/2022 | 390.96% | Truist Securities | $53 → $38 | Maintains | Buy |
| 03/03/2022 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 02/28/2022 | 390.96% | Jefferies | $54 → $38 | Downgrades | Buy → Hold |
| 02/23/2022 | 649.35% | Stifel | $70 → $58 | Maintains | Buy |
| 11/09/2021 | 739.79% | Keybanc | $70 → $65 | Maintains | Overweight |
| 10/27/2021 | 571.83% | Goldman Sachs | → $52 | Initiates Coverage On | → Neutral |
| 10/26/2021 | 868.99% | Cowen & Co. | → $75 | Upgrades | Market Perform → Outperform |
| 09/15/2021 | 597.67% | Wells Fargo | → $54 | Initiates Coverage On | → Equal-Weight |
| 06/28/2021 | 946.51% | Stifel | $75 → $81 | Maintains | Buy |
| 04/21/2021 | 752.71% | Jefferies | → $66 | Initiates Coverage On | → Buy |
| 04/08/2021 | 804.39% | Keybanc | $65 → $70 | Maintains | Overweight |
| 03/05/2021 | 804.39% | Stifel | → $70 | Upgrades | Hold → Buy |
| 01/14/2021 | 739.79% | KeyBanc | → $65 | Initiates Coverage On | → Overweight |
| 11/19/2020 | 352.2% | Macquarie | → $35 | Initiates Coverage On | → Outperform |
What is the target price for Ballys (BALY)?
The latest price target for Ballys (NYSE: BALY) was reported by Barclays on November 2, 2023. The analyst firm set a price target for $10.00 expecting BALY to rise to within 12 months (a possible 29.20% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ballys (BALY)?
The latest analyst rating for Ballys (NYSE: BALY) was provided by Barclays, and Ballys maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Ballys (BALY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ballys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ballys was filed on November 2, 2023 so you should expect the next rating to be made available sometime around November 2, 2024.
Is the Analyst Rating Ballys (BALY) correct?
While ratings are subjective and will change, the latest Ballys (BALY) rating was a maintained with a price target of $12.00 to $10.00. The current price Ballys (BALY) is trading at is $7.74, which is out of the analyst's predicted range.